This inventor holds 13 USPTO granted patents and 6 published patent applications and 3 EPO patents, primarily in Pharmaceutical Delivery. Top assignees: Neurelis, Inc., Hale Biopharma Ventures, LLC, Other. Active years: 1977-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mountain Home, AR (US) (1977)
- Somerset, WI (US) (2017 - 2020)
- San Diego, CA (US) (2014 - 2023)
Company Filing History:
Years Active: 1977-2026
Areas of Expertise:
Title: David F Hale: Innovator in Pharmaceutical Compositions
Introduction
David F Hale is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of benzodiazepine compositions. With a total of 13 patents to his name, Hale's work has had a notable impact on medical treatments.
Latest Patents
Hale's latest patents focus on the administration of benzodiazepine compositions. These inventions relate to pharmaceutical compositions that comprise one or more benzodiazepine drugs for nasal administration. The methods for producing and using such compositions are designed to enhance the efficacy and delivery of these important medications.
Career Highlights
Throughout his career, Hale has worked with several notable companies, including Neurelis, Inc. and Hale Biopharma Ventures, LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to advancements in drug delivery systems.
Collaborations
Hale has collaborated with various professionals in the industry, including Steve Cartt and David Medeiros. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David F Hale's contributions to the field of pharmaceuticals, particularly through his patents on benzodiazepine compositions, highlight his role as a key innovator. His work continues to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile